Case Study: International Phase III Psoriasis

A leading global pharmaceutical company selected Novella Clinical to support four large, international Phase III biologic studies in moderate to severe psoriasis. Novella’s Dermatology Division was selected because of its proven patient recruitment process with a record of enrollment that could save the sponsor time and money. Successful patient recruitment strategies in 13 countries, where some are unfamiliar with advertising, surpassed enrollment projections.